These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
237 related items for PubMed ID: 21874315
1. The intact strontium ranelate complex stimulates osteoblastogenesis and suppresses osteoclastogenesis by antagonizing NF-κB activation. Yamaguchi M, Weitzmann MN. Mol Cell Biochem; 2012 Jan; 359(1-2):399-407. PubMed ID: 21874315 [Abstract] [Full Text] [Related]
2. Dual effect of strontium ranelate: stimulation of osteoblast differentiation and inhibition of osteoclast formation and resorption in vitro. Bonnelye E, Chabadel A, Saltel F, Jurdic P. Bone; 2008 Jan; 42(1):129-38. PubMed ID: 17945546 [Abstract] [Full Text] [Related]
4. Vitamin K2 stimulates osteoblastogenesis and suppresses osteoclastogenesis by suppressing NF-κB activation. Yamaguchi M, Weitzmann MN. Int J Mol Med; 2011 Jan; 27(1):3-14. PubMed ID: 21072493 [Abstract] [Full Text] [Related]
5. Strontium ranelate: a dual mode of action rebalancing bone turnover in favour of bone formation. Marie PJ. Curr Opin Rheumatol; 2006 Jun; 18 Suppl 1():S11-5. PubMed ID: 16735840 [Abstract] [Full Text] [Related]
6. Zinc stimulates osteoblastogenesis and suppresses osteoclastogenesis by antagonizing NF-κB activation. Yamaguchi M, Weitzmann MN. Mol Cell Biochem; 2011 Sep; 355(1-2):179-86. PubMed ID: 21533765 [Abstract] [Full Text] [Related]
7. Strontium as therapy for osteoporosis. Marie PJ. Curr Opin Pharmacol; 2005 Dec; 5(6):633-6. PubMed ID: 16183330 [Abstract] [Full Text] [Related]
11. Strontium ranelate: a new treatment for postmenopausal osteoporosis with a dual mode of action. Reginster JY, Sarlet N, Lejeune E, Leonori L. Curr Osteoporos Rep; 2005 Mar; 3(1):30-4. PubMed ID: 16036099 [Abstract] [Full Text] [Related]
12. The calcium-sensing receptor is involved in strontium ranelate-induced osteoclast apoptosis. New insights into the associated signaling pathways. Hurtel-Lemaire AS, Mentaverri R, Caudrillier A, Cournarie F, Wattel A, Kamel S, Terwilliger EF, Brown EM, Brazier M. J Biol Chem; 2009 Jan 02; 284(1):575-584. PubMed ID: 18927086 [Abstract] [Full Text] [Related]
13. Exogenous regucalcin stimulates osteoclastogenesis and suppresses osteoblastogenesis through NF-κB activation. Yamaguchi M, Weitzmann MN, Murata T. Mol Cell Biochem; 2012 Jan 02; 359(1-2):193-203. PubMed ID: 21842421 [Abstract] [Full Text] [Related]
14. [Strontium Ranelate as a new therapeutic agent for osteoporosis]. Imanishi Y, Nishizawa Y. Clin Calcium; 2005 Jan 02; 15(1):25-8. PubMed ID: 15632469 [Abstract] [Full Text] [Related]
20. Comprehensive therapy in osteoporosis using a single drug: from ADFR to strontium ranelate. Manette C, Collette J, Sarlet N, Tancredi A, Zegels B, Reginster JY. Curr Med Chem; 2006 Sep 02; 13(13):1585-90. PubMed ID: 16787205 [Abstract] [Full Text] [Related] Page: [Next] [New Search]